View Older Stories

Dec 8, 2025 07:22PM Bausch Health Announces Early Exchange Offer Results for Exchange Offers

Dec 1, 2025 07:01AM Bausch Health's Solta Medical acquires China distributor Shibo Group

Dec 1, 2025 07:00AM Bausch Health's Aesthetics Business, Solta Medical, Acquires Longtime Distribution Partner, the Shibo Group, to Strengthen Presence in China

Nov 24, 2025 07:05AM Bausch Health launches $1.6 billion debt exchange offer

Nov 24, 2025 07:05AM Bausch Health Announces Launch of Offers to Exchange Certain Existing Senior Secured Notes

Nov 18, 2025 07:00AM Bausch Health to Participate in the 8th Annual Evercore Healthcare Conference

Nov 13, 2025 07:01AM Bausch + Lomb sets three-year growth targets at investor day

Nov 5, 2025 08:03AM Bausch Health expands OraPharma dental unit to Canada and Puerto Rico

Nov 5, 2025 08:00AM Bausch Health's OraPharma Expands into Canada and Puerto Rico, Helping to Address Unmet Needs in Periodontal Disease

Oct 30, 2025 12:51AM Bausch Health Co. Inc. (BHC) Misses Q3 EPS by 56c

Oct 29, 2025 04:05PM Bausch Health Announces Third Quarter 2025 Results

Oct 9, 2025 07:00AM Bausch Health Announces Results of Special Meeting of Shareholders

Sep 30, 2025 08:00AM Bausch Health's Aesthetic Business, Solta Medical, Brings Non-Invasive Aesthetic Innovations to National TV

Sep 30, 2025 07:00AM Bausch Health to Announce Third Quarter 2025 Results on October 29

Sep 29, 2025 08:00AM Bausch Health's OraPharma Introduces "OraTalks," a New Podcast Bringing Bold Conversations to Dentistry

Sep 11, 2025 08:35AM Bausch Health completes $63 million DURECT acquisition

Sep 11, 2025 08:35AM Bausch Health Completes Acquisition of DURECT Corporation, Expanding Late-stage Liver Disease Portfolio

Sep 5, 2025 08:02AM Solta Medical reaches 5 million Thermage skin treatments milestone

Sep 5, 2025 08:02AM Bausch Health's Aesthetic Business, Solta Medical, Surpasses Milestone of 5 Million Skin Tightening Treatments with Thermage(R) Non-Surgical System

Aug 26, 2025 08:00AM Bausch Health Announces Extension of DURECT Corporation Tender Offer to September 10, 2025

Aug 21, 2025 08:02AM Bausch Health expands CABTREO acne treatment to Quebec, Saskatchewan plans

Aug 21, 2025 08:02AM Bausch Health, Canada Inc. Treatment for Acne Vulgaris, (Pr)CABTREO(TM) (Clindamycin Phosphate, Adapalene and Benzoyl Peroxide Gel), Now Available Through Public Drug Plans of Quebec and Saskatchewan

Aug 15, 2025 02:30PM Paulson Capital increases Bausch Health stake to 19% after Icahn exit

Aug 15, 2025 02:30PM Bausch Health Announces Increase in Shareholding by its Chairperson of the Board and Board Changes

Aug 7, 2025 08:00AM Bausch Health Announces 2025 Gastrointestinal Health Scholars Program Winners

Jul 30, 2025 05:06PM Bausch Health Co. Inc. (BHC) Tops Q2 EPS by 36c

Jul 30, 2025 04:47PM Bausch Health Co. Inc. (BHC) Misses Q2 EPS by 54c, provides guidance

Jul 30, 2025 04:05PM Bausch Health Announces Second Quarter 2025 Results

Jul 29, 2025 07:00AM Bausch Health to acquire DURECT for $63 million upfront

Jul 29, 2025 07:00AM Bausch Health to Acquire DURECT Corporation, Strengthening Commitment to Developing Innovative Solutions for Patients with Liver Disease

Jul 28, 2025 09:11AM Bausch Health to reduce debt by $900 million using cash on hand

Jul 28, 2025 09:10AM Bausch Health to Reduce Debt by Approximately $900 Million Using Cash On Hand

Jul 24, 2025 08:02AM Bausch Health adds two pharmaceutical executives to board

Jul 24, 2025 08:02AM Bausch Health Announces the Appointment of Two New Members to Its Board of Directors

Jul 10, 2025 05:00PM CORRECTING and REPLACING: Bausch Health, Canada Inc. Treatment for Acne Vulgaris, (Pr)CABTREO(TM) (clindamycin phosphate, adapalene and benzoyl peroxide gel), Now Available Through Public Drug Plans o

Jul 10, 2025 04:16PM Bausch Health names Steven Lee as chief accounting officer

Jul 10, 2025 04:15PM Bausch Health Appoints New Chief Accounting Officer

Jul 9, 2025 08:00AM Bausch Health, Canada Inc. Treatment for Acne Vulgaris, (Pr)CABTREO(TM) (clindamycin phosphate, adapalene and benzoyl peroxide gel), Now Available Through Public Drug Plans of Ontario, Quebec and Two

Jul 7, 2025 08:00AM Bausch Health's Gastroenterology Business, Salix Pharmaceuticals, Launches Fresh "I Wish I Knew" Campaign to Educate People About Xifaxan(R) (rifaximin) for Adults at Risk of Overt Hepatic Encephalopa

Jul 2, 2025 07:00AM Bausch Health to Announce Second Quarter 2025 Results on July 30

May 14, 2025 04:15PM Bausch Health Announces 2025 Annual Meeting of Shareholder Results

May 12, 2025 11:36AM Truist Lays Out Prelim Thoughts on Impact to Generic Drugs Amid WH Update on Drug Pricing

May 6, 2025 08:00AM Xifaxan(R) (rifaximin) Treatment Following Overt Hepatic Encephalopathy (OHE) Hospitalization Associated with Reduced Risk of 30-Day OHE Rehospitalization

May 5, 2025 02:42PM Bausch Health Companies (BHC) PT Lowered to $8 at Raymond James

Apr 30, 2025 04:05PM Bausch Health Announces First Quarter 2025 Results

Apr 29, 2025 08:04AM Bausch Health Co. Inc. (BHC) nnounces Health Canada Clearance of Solta Medical's Thermage FLX System

Apr 29, 2025 08:00AM Bausch Health Announces Health Canada Clearance of Solta Medical's Thermage(R) FLX System

Apr 25, 2025 08:02AM Bausch Health Co. Inc. (BHC) Announces Launch of Solta Medical's Fraxel FTX

Apr 25, 2025 08:00AM Bausch Health Announces Launch of Solta Medical's Fraxel FTX(TM)

Apr 22, 2025 07:39AM Bausch Health Co. Inc. (BHC) Says Icahn Has Economic Interest Covering Approximately 34% of Outstanding Shares

View Older Stories